Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Imaging data from clinical trials provides the opportunity to  link imaging characteristics to clinical trial analyses, associated clinical data and patient outcomes.  Beginning in 2019From 2018 to 2023, the NCI Cancer Imaging Program Informatics Lab is supporting supported an additional TCIA  additional TCIA  image data collection center focused specifically on clinical trial data.   Many TCIA clinical trial data sets will originate from the NCI NCI National Clinical Trials Network (NCTN), which is a collection of organizations and clinicians that coordinates and supports cancer clinical trials at more than 3,000 sites across the United States and Canada. The NCTN provides the infrastructure for NCI-funded treatment, screening, and diagnosis trials to improve the lives of patients with cancer.  The NCTN explicitly requires data sharing of the patient-level clinical data in https://nctn-data-archive.nci.nih.gov/view-trials, and TCIA serves as the imaging repository for that archive.  

...


Collection NameClinicalTrials.gov IDPublished on TCIAImage Annotations
1EA1141NCT029334892 October 2023Not available
2S0819NCT0094671230 March 2023Tumor segmentations and seed points (3rd party analysis)
3A091105NCT0206618110 February 2023Tumor segmentations and seed points (3rd party analysis)
4ARAR0331
NCT0027493721 October 2022Tumor segmentations and seed points (3rd party analysis)
5AHOD0831NCT010262208 June 2022Tumor segmentations and seed points (3rd party analysis)
62ACRIN-6698NCT015643682 May 2022Tumor segmentations included in primary dataset
73I-SPY2 TrialNCT010423792 May 2022Tumor segmentations included in primary dataset
84AREN0532NCT0035253431 March 2022Tumor segmentations and seed points (3rd party analysis)
95AREN0533NCT0037934020 January 2022Tumor segmentations and seed points (3rd party analysis)
106AREN0534NCT009450098 November 2021Tumor segmentations and seed points (3rd party analysis)
117ACNS0332NCT003923274 May 2021Tumor segmentations and seed points (3rd party analysis)
128AHEP0731NCT0098046030 March 2021Tumor segmentations and seed points (3rd party analysis)
139CALGB50303NCT0011820930 March 2021Tumor segmentations and seed points (3rd party analysis)
1410ACRIN-Contralateral-Breast-MR (ACRIN 6667)NCT000580585 March 2021Not available
1511ACRIN-HNSCC-FDG-PET/CT (ACRIN 6685)NCT00983697 13 March 2020Tumor segmentations and seed points (3rd party analysis)
1612ACRIN-DSC-MR-Brain (ACRIN 6677/RTOG 0625)NCT00433381 7 February 2019Not available
1713NSCLC-Cetuximab (RTOG-0617)NCT00533949 15 April 2019Radiation Therapy Structures included in primary dataset
1814ACRIN-NSCLC-FDG-PET (ACRIN 6668)NCT00083083 31 December 2018Not available
1915ACRIN-FMISO-Brain (ACRIN 6684)NCT00902577 12 February 2018Not available
2016ACRIN-FLT-Breast (ACRIN 6688)NCT0057272811 December 2017Not available
2117ISPY1 (ACRIN 6657)NCT0004301718 June 2015
  1. Segmentations included in primary dataset
  2. Tumor segmentations (3rd party analysis)
2218NRG-1308 (RTOG 1308)NCT0199381014 September 2015Radiation Therapy Structures included in primary dataset
2319National Lung Screening TrialNCT000473851 March 2013Not available
2420Head-Neck Cetuximab (RTOG 0522)NCT00265941 

14 November 2013

Radiation Therapy Structures included in primary dataset

2521CT Colonography (ACRIN 6664)NCT00084929 15 November 2013Not available